Beck Depression Inventory (BDI); higher score means more depression · people with ESKD
Exercise showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Cognitive‐behavioural therapy showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Relaxation techniques showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Beck Depression Inventory (BDI); higher score means more depression · people with ESKD
It is very uncertain whether spiritual practice changes depression (any severity, including mild, moderate and severe… compared with usual care (very low certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Counselling showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (low certainty).
1 finding from 1 review
Pain: presence of pain (slight or moderate) at 1 year · adults with acute acromioclavicular dislocation of the shouldera
It is very uncertain whether surgical intervention changes pain: presence of pain (slight or moderate) at 1 year compared with conservative intervention (very low certainty).
1 finding from 1 review
Patient Global Impression of Change · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue Mental fatigue in moderate‐grade hepatic encephalopathy Wessely and Powell test Scale from 0 to 10 · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
Adverse events: gastrointestinal – dyspeptic symptoms – self‐assessed as at least 'moderate' · patients with schizophrenia
It is very uncertain whether aspirin plus antipsychotics changes adverse events: gastrointestinal – dyspeptic symptoms –… compared with placebo plus antipsychotics (very low certainty).
1 finding from 1 review
Primary outcome: adverse events (assessed at 3 months as minimum, moderate or severe) · ulceration caused by nerve damage in leprosy
1 finding from 1 review
Recurrence of ITW post‐treatment Assessed by improvement in toe walking based on Gait Analysis Classification An increase indicates improvement (an improvement indicated by a change in downgrading of the severe or 3, moderate or 2, and mild or 1 c... · children with ITW gait
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention showed no clear difference in moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention showed no clear difference in moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12 months and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review